Multiple AbbVie Oncology Trials to Launch on the Inato Marketplace
A bundle of oncology trials from AbbVie is coming to the Inato marketplace.
A bundle of oncology trials from AbbVie is coming to the Inato marketplace.
Joined by industry experts, Liz Beatty explored the implications of changing demographics on clinical trial design, participant recruitment, and...
Discover how Inato secured a spot in Fast Company's prestigious ranking of the most innovative companies in 2024.
Inato Co-Founder and Chief Strategy Officer, Liz Beatty, sat down with Dr. Daniel Fox and Monica Cuitiva from Save Our Sites to break down how Inato...
After moderating ACRP's webinar, Liz Beatty, shares how to turn the discussion into action with three key takeaways to guide the industry forward.
ACRP recently hosted the Broadening Your Approach to Trial Diversity on a Global Scale webinar in collaboration with Inato, bringing together unique...
A look behind the scenes into the development of Inato's newest site user updates released in May, 2023.
Liz Beatty sat down with Dan Sfera, The Clinical Trials Guru, to talk empowering sites and improving the way sites find and get selected for trials.
Inato co-founders sat down for a transparent conversation with Brad Hightower to explore Inato’s mission, better understand how the platform works to...
At SCOPE 2023, four members of Inato's team presented on the advantages community-based sites bring to clinical research.
Last month, Hernandez-Aldama joined Inato’s Marketing Lead, Laurel Uballez, and Senior DE&I Growth Manager, Atira Goodwin for a conversation on...
This month, in the spirit of giving thanks, our team at Inato reached out to collaborators across our network to hear what they're grateful for.
After listening to and collaborating with our network of community research centers, we’ve created Check Your Fit as a way to inform sites on whether...
Inato Co-Founder and CEO, Kourosh Davarpanah, sat down with fellow industry leaders to address community-based solutions to the barriers disrupting...
How to dramatically accelerate clinical trials and sustain lower costs in complex and competitive environments
Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco, where he is the Holly...
In an effort to increase patient access to innovative investigational medicines, Sanofi will partner with Inato to connect with community-based sites...
Christophe Massard, MD PhD is a medical oncologist and the department head at Drug Development Department (DITEP) in Paris, France. He is a member of...
On Thursday June 18th between 12:00 - 1:00 pm EST, Inato hosted a discussion on how to secure more clinical trials for your site
In alignment with a mission to broaden clinical trial access worldwide, Inato has seen major growth across its network in 2022.
Despite the nationwide incidence rate being lower than that of white women, Black women face a 41% higher death rate accompanying a breast cancer...
Inato Senior DE&I Growth Manager, Atira Goodwin sits down with Greater Gift Director of Community Outreach, Perla Nunes, for a deep dive on how we...
Community-based sites’ untapped patient populations, strong community bonds, and personal patient-physician relationships are the keys to unlocking...
With clinical trial budget negotiation being one of the biggest contributors to lost time during study start-up, a transformation towards efficiency...
To a crowded room of pharma leaders, Inato’s Liz Beatty and Otsuka’s Candace Saldarini presented their teams’ findings on how collaborating with...
Today’s clinical trials struggle to include diverse patient populations due to limited, centralized trial sites that are not easily accessible for...
Community sites bring powerful access to more patients and more diverse populations. They have many unique advantages that make them key to the...
Whether you’re focused on finding a specific type of clinical trial for your patients or working to line up more trials for your research center,...
Despite an overarching goal to save lives through medicine, the clinical trial industry leaves behind a crushing carbon footprint.
Striving for diversity across trials means striving for the inclusion of members of the LGBTQ+ community as well and recognizing gaps in research and...
Founded on a commitment to provide patients in Detroit, Michigan with high quality research opportunities, Great Lakes Research Institute brings...
A lupus diagnosis means a lifelong battle with inflammation, be it in the skin, joints, blood cells, brain, kidney, or heart and, at present, there...
Across the globe, Alzheimer’s Dementia is steadily increasing to epidemic proportions with nearly 55 million adults living with Alzheimer’s and other...
Throughout Women’s History Month, we reached out to leaders in the clinical trial industry to hear their perspectives on women’s health and...
Despite making up 47% of the U.S. workforce, women only account for 28% of tech leadership positions. It’s a steady cycle of underrepresentation...
As the medical field has come to better understand gender disparities, the startling realization has emerged that many medications on the market...
Inato’s Liz Beatty spoke alongside Sanofi’s Kim Hawkins to present how their teams worked together to accelerate and diversify trials.
Since opening, iResearch’s mission has been to treat, educate, and assist the community in any way they can. With 50% of their patient database...
At a Marcus Evans webinar, site and sponsor leaders held a virtual discussion considering innovative approaches to establishing a more inclusive...
The continuation of the pandemic in 2021 lead to defining new trends in pharma, pushing clinical trials towards inclusivity, innovation, and...
Inato’s Chief Strategy Officer Liz Beatty recently sat down with Liam Eves, host of The Endpoint Podcast, to discuss trends in clinical research.
Hear from site leaders on the value their community-based centers bring to clinical trials.
Get a behind-the-scenes look at what's important to clinical trial leaders.
Last month, Inato spoke with 13 research sites around the world to gather information on their capabilities to perform in an RSV vaccine trial.
After working as the Clinical Trial Director at a large research center for twelve years, Dr. Jaswinder Singh, Director of the MidAmerica Cancer...
During a live webinar, sponsor leaders shared their experiences working with community sites.
Building stronger relationships between sites and sponsors leads to accelerated recruitment, increased diversity, and better patient engagement.
Hear from clinical leaders at Inato, LMC Manna Research and The Society for Clinical Research Sites.
Inato hosted a panel discussion in partnership with Marcus Evans, Sanofi and The Center for Cancer Prevention and Treatment.
The evidence-based diversity assessment allows sponsors to easily match their protocols to sites in the Inato Marketplace with expertise in...
Inato's strategic transition from a feasibility platform to offering a two-sided marketplace that matches clinical research sites to the sponsor...
Doctors grappling with fragmented data sources on COVID-19 trials can use Inato's Anticovid Platform to search trials, analyze trends, and act...
How Inato builds a platform that is designed around the needs and challenges of doctors worldwide